Study protocol for a multicentre, prospective cohort study of the association of angiotensin II type 1 receptor blockers on outcomes of coronavirus infection
Introduction The COVID-19 epidemic grows and there are clinical trials of antivirals. There is an opportunity to complement these trials with investigation of angiotensin II type 1 receptor blockers (ARBs) because an ARB (losartan) was effective in murine influenza pneumonia.Methods and analysis Our...
Sparad:
| Huvudupphov: | , , , , , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
BMJ Publishing Group
2020-12-01
|
| Serie: | BMJ Open |
| Länkar: | https://bmjopen.bmj.com/content/10/12/e040768.full |
| Taggar: |
Inga taggar, Lägg till första taggen!
|